Industry Bulletins | January 8, 2020
DarioHealth Announces Closing Of $21.3 Million Private Placement
DarioHealth Corp., a pioneer in the global digital therapeutics market, announced that it has closed on a private placement of convertible preferred stock to institutional and private investors. The company received aggregate gross proceeds of approximately $21.3 million, before deducting placement agent fees and other offering expenses payable by the company. The capital raised from both existing and new investors will fund DarioHealth's strategic plan, which includes accelerating the company's initiatives in the Business-to-Business (B2B) channel while continuing to support the direct-to-consumer (D2C) sales and marketing initiatives.
The proceeds will be primarily used . . .